Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Consulting agrmnt
Director departure
Appointed COO
Appointed director
Organicell Regenerative Medicine, Inc. (BPSR) Create: Alert

All | News | Filings
Date FiledTypeDescription
09/28/2023 PRE 14C Form PRE 14C - Other preliminary information statements:
08/25/2023 D Form D - Notice of Exempt Offering of Securities:
08/14/2023 DEF 14C Form DEF 14C - Other definitive information statements:
08/09/2023 8-K Completion of Acquisition or Disposition of Assets  Interactive Data
08/01/2023 PRE 14C Form PRE 14C - Other preliminary information statements:
07/26/2023 8-K Quarterly results
07/11/2023 8-K Quarterly results
07/11/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/30/2023 4 Skycrest Holdings, LLC (10% Owner) has filed a Form 4 on Organicell Regenerative Medicine, Inc.
Txns: Bought 400,000 shares @ $0.009, valued at $3.6k
Bought 200,000 shares @ $0.009, valued at $1.8k
06/30/2023 4 Leider Harry L. (CEO) has filed a Form 4 on Organicell Regenerative Medicine, Inc.
Txns: Bought 549,450 shares @ $0.099, valued at $54.4k
Bought 500,000 shares @ $0.01, valued at $5k
06/29/2023 8-K Regulation FD Disclosure, Financial Statements and Exhibits  Interactive Data
Docs: "Organicell Welcomes Howard Golub, MD, PhD as its New EVP/CSO Fort Lauderdale, FL / June 29, 2023 / Organicell Regenerative Medicine, Inc. , a clinical-stage biopharmaceutical company focused on the development of innovative biological regenerative therapeutics, is pleased to announce the appointment of Howard L. Golub, MD, PhD as its new Executive Vice President and Chief Science Officer . Dr. Golub has a distinguished background as a highly innovative healthcare executive and entrepreneur with extensive experience serving in C-suite roles – in both early-stage and large companies. Dr. Golub's exceptional career spans over 30 years of success advancing breakthroughs in the development of clinical therapeutics. Dr. Golub is the founder and a principal at Care-Safe LLC - a clinical research ..."
06/28/2023 4 Skycrest Holdings, LLC (10% Owner) has filed a Form 4 on Organicell Regenerative Medicine, Inc.
Txns: Bought 800,000 shares @ $0.009, valued at $7.2k
06/16/2023 10-Q Quarterly Report for the period ended April 30, 2023
06/09/2023 3 Golub Howard Lawrence (Executive Vice President & CSO) has filed a Form 3 on Organicell Regenerative Medicine, Inc.
06/09/2023 3 Leider Harry L. (CEO and Director) has filed a Form 3 on Organicell Regenerative Medicine, Inc.
06/09/2023 8-K Other Events  Interactive Data
06/06/2023 8-K Investor presentation
Docs: "Employment Agreement with Dr. Harry Leider",
"Employment Agreement with Dr. Howard L. Golub",
"of the Private Securities Litigation Reform Act of 1995"
05/01/2023 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
04/21/2023 8-K Quarterly results
03/17/2023 10-Q Quarterly Report for the period ended January 31, 2023
03/08/2023 8-K Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S...
Docs: "SECURITIES PURCHASE AGREEMENT This SECURITIES PURCHASE AGREEMENT , dated as of March 6, 2023, by and between ORGANICELL REGENERATIVE MEDICINE, INC., a Nevada corporation, with headquarters located at 3321 College Avenue, Suite 246, Davie, FL 33314 , and AJB CAPITAL INVESTMENTS, LLC, a Delaware limited liability company, with its address at 4700 Sheridan Street, Suite J, Hollywood, FL 33021 . WHEREAS: A. The Company and the Buyer are executing and delivering this Agreement in reliance upon the exemption from securities registration afforded by the rules and regulations as promulgated by the United States Securities and Exchange Commission under the Securities Act of 1933, as amended ; B. The Buyer desires to purchase and the Company desires to issue and sell, upon the terms and conditions s...",
"Promissory Note made in favor of AJB Capital Investments",
"Warrant issued to AJB Capital Investments"
01/30/2023 NT 10-K Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405:
12/30/2022 SC 13D Form SC 13D - General statement of acquisition of beneficial ownership:
12/23/2022 8-K Quarterly results
12/16/2022 3 Form 3 - Initial statement of beneficial ownership of securities:
12/01/2022 8-K Quarterly results
11/25/2022 8-K Quarterly results
11/21/2022 8-K Quarterly results
11/03/2022 4/A Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
11/01/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/27/2022 3 Form 3 - Initial statement of beneficial ownership of securities:
10/25/2022 EFFECT Form EFFECT - Notice of Effectiveness:
10/20/2022 S-1/A Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
10/17/2022 4 Sinnreich Matthew Phillip (President and Acting CEO) has filed a Form 4 on Organicell Regenerative Medicine, Inc.
Txns: Sold 20,000 shares @ $0.04, valued at $800
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy